Cabaletta Bio, Inc.
CABA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $5 | $1 | $4 | $1 |
| Gross Profit | -$5 | -$1 | -$4 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $97 | $55 | $39 | $32 |
| G&A Expenses | $0 | $19 | $0 | $0 |
| SG&A Expenses | $23 | $19 | $11 | $13 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$1 | $0 | $0 |
| Operating Expenses | $120 | $73 | $50 | $46 |
| Operating Income | -$125 | -$75 | -$54 | -$46 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $9 | $7 | $1 | $0 |
| Pre-Tax Income | -$116 | -$68 | -$53 | -$46 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$116 | -$68 | -$53 | -$46 |
| % Margin | – | – | – | – |
| EPS | -2.34 | -1.65 | -1.81 | -1.8 |
| % Growth | -41.8% | 8.8% | -0.6% | – |
| EPS Diluted | -2.34 | -1.65 | -1.81 | -1.8 |
| Weighted Avg Shares Out | 50 | 41 | 29 | 26 |
| Weighted Avg Shares Out Dil | 49 | 41 | 29 | 26 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $7 | $1 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $1 | $4 | $1 |
| EBITDA | -$110 | -$66 | -$49 | -$46 |
| % Margin | – | – | – | – |